Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents

Christina L. Szperka, Juliana VanderPluym, Serena L. Orr, Christopher B. Oakley, William Qubty, Irene Patniyot, Ana Marissa Lagman-Bartolome, Cynthia Morris, Jessica Gautreaux, M. Cristina Victorio, Suzanne Hagler, Sona Narula, Meghan S. Candee, Catalina Cleves-Bayon, Rashmi Rao, Robert H. Fryer, Alma R. Bicknese, Marcy Yonker, Andrew D. Hershey, Scott W. PowersPeter J. Goadsby, Amy A. Gelfand

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1658-1669
Number of pages12
JournalHeadache
Volume58
Issue number10
DOIs
StatePublished - Nov 1 2018

Keywords

  • adolescent
  • calcitonin gene-related peptide
  • migraine
  • monoclonal antibody
  • pediatric

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Szperka, C. L., VanderPluym, J., Orr, S. L., Oakley, C. B., Qubty, W., Patniyot, I., Lagman-Bartolome, A. M., Morris, C., Gautreaux, J., Victorio, M. C., Hagler, S., Narula, S., Candee, M. S., Cleves-Bayon, C., Rao, R., Fryer, R. H., Bicknese, A. R., Yonker, M., Hershey, A. D., ... Gelfand, A. A. (2018). Recommendations on the Use of Anti-CGRP Monoclonal Antibodies in Children and Adolescents. Headache, 58(10), 1658-1669. https://doi.org/10.1111/head.13414